✦ LIBER ✦

Optimal treatments in cost-effectiveness analysis in the presence of covariates: Improving patient subgroup definition

✍ Scribed by Moreno, E.; Girón, F.J.; Martínez, M.L.; Vázquez-Polo, F.J.; Negrín, M.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal healthcare decisions: The import

✍ Elías Moreno; F.J. Girón; F.J. Vázquez-Polo; M.A. Negrín 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 582 KB

Cost Effectiveness Analysis Of Alverine/

✍ Soto, H.; Pizarro, M.; Botello, B.S.; Rizzoli, A.; Toriz, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PRS25 A COST-UTILITY ANALYSIS FOR TIOTRO

✍ O Zaniolo; S Iannazzo; M Carsi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Cost-Effectiveness Analysis of Cysteamin

✍ Walczak, J.; Stelmachowski, J.; Obrzut, G.; Hubert, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Abatacept For The Treatment Of Patients

✍ Elgart, J.F.; Gonzalez, L.; Aiello, E.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Cost-Effectiveness and Cost-Utility Anal

✍ Gouveia, M.; Borges, M.; Augusto, M.; Costa, J.; Treur, M.; Lopes, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB